Who
Steven Perrin
President
Company insider
Files Form 4 as: President, Eledon Pharmaceuticals.
In numbers
- Trades disclosed
- 12
- Buys
- 1
- Sells
- 0
- Bought
- $2,600
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Feb 2022
- Last trade
- 31 Jul 2026
- Last filed
- 4 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 4 Aug 2026 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —152,353 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $244K72,138 at $3.38 | filing |
| 31 Jul 2026filed 4 Aug 2026 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —152,353 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $244K72,138 at $3.38 | filing |
| 10 Jan 2025filed 13 Jan 2025 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —243,000 at $0.00 | filing |
| 10 Jan 2025filed 13 Jan 2025 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 21 Nov 2024filed 22 Nov 2024 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —840,438 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —428,148 at $0.00 | filing |
| 1 May 2023filed 2 May 2023 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —317,147 at $0.00 | filing |
| 1 Feb 2023filed 2 Feb 2023 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —155,000 at $0.00 | filing |
| 23 Nov 2022filed 23 Nov 2022 | ELDN Eledon PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $2,6001,000 at $2.60 | filing |
| 1 Feb 2022filed 2 Feb 2022 | ELDN Eledon Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —155,000 at $0.00 | filing |
News
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual MeetingELDN · manilatimes.net · 5 Oct 2026
0 headlines in the last 90 days name Steven Perrin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.